Abciximab Intravenous and Methylphenidate Controlled-Release Tablets
Determining the interaction of Abciximab Intravenous and Methylphenidate Controlled-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abciximab
Brand name: ReoPro
Synonyms: Abciximab
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abciximab Intravenous-Methylphenidate ER Capsules
- Abciximab Intravenous-Methylphenidate Extended-Release Capsules (Evening Formulation)
- Abciximab Intravenous-Methylphenidate Extended-Release Chewable Tablets
- Abciximab Intravenous-Methylphenidate Extended-Release Oral Suspension
- Abciximab Intravenous-Methylphenidate Extended-Release Oral-Disintegrating Tablets
- Abciximab Intravenous-Methylphenidate Extended-Release Tablets
- Methylphenidate Controlled-Release Tablets-ABDEK
- Methylphenidate Controlled-Release Tablets-Abelcet
- Methylphenidate Controlled-Release Tablets-Abemaciclib
- Methylphenidate Controlled-Release Tablets-Abenol
- Methylphenidate Controlled-Release Tablets-Abilify
- Methylphenidate Controlled-Release Tablets-Abilify (Aripiprazole Injection)